306761-55-7 Usage
Specific content
The chemical name of the compound
Specific content
The common name or brand name for the compound
Specific content
The category of drugs to which 2-(3,4-Difluorophenyl)-2-Methylpropanoic acid belongs
Specific content
The primary uses of the drug
Specific content
How the drug exerts its therapeutic effects
Specific content
Specific medical conditions for which the drug is often prescribed
Specific content
The forms in which the drug can be purchased
Specific content
The physical form of the drug when taken orally
Specific content
Typical adverse effects experienced by users of the drug
Specific content
The importance of adhering to the guidance provided by a medical professional to avoid adverse effects
Classification
Nonsteroidal anti-inflammatory drug (NSAID)
Function
Treats mild to moderate pain, reduces inflammation, and fever
Mechanism of action
Blocks the production of natural substances causing pain and inflammation
Prescribed conditions
Arthritis, menstrual cramps, and muscle aches
Availability
Prescription and over-the-counter forms
Form
Tablets
Common side effects
Stomach upset, heartburn, and dizziness
Dosage and administration
Follow healthcare professional's instructions
Check Digit Verification of cas no
The CAS Registry Mumber 306761-55-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,6,7,6 and 1 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 306761-55:
(8*3)+(7*0)+(6*6)+(5*7)+(4*6)+(3*1)+(2*5)+(1*5)=137
137 % 10 = 7
So 306761-55-7 is a valid CAS Registry Number.
306761-55-7Relevant academic research and scientific papers
NAPHTHALENONE COMPOUNDS EXHIBITING PROLYL HYDROXYLASE INHIBITORY ACTIVITY, COMPOSITIONS, AND USES THEREOF
-
Page/Page column 163, (2008/12/06)
Compounds of Formula (I) and Formula (II) are useful as inhibitors of HIF prolyl hydroxylases. Compounds of Formula(I) and Formula (II) have the following structures, where the definitions of the variables are provided herein.
MELANIN-CONCENTRATING HORMONE RECEPTOR ANTAGONISTS CONTAINING PIPERIDINE DERIVATIVES AS THE ACTIVE INGREDIENT
-
Page/Page column 27, (2010/02/14)
The invention provides melanin-concentrating hormone receptor antagonists containing as the active ingredient piperidine derivatives represented by the general formula [I]: ???[wherein R1 is hydrogen, hydroxyl, lower alkyl, or the like; R2, R3a, R3b, R4a, R4b, R5a, R5b and R6 each stands for hydrogen, halogen, or the like; W1 and W2 each independently stands for -O-, -CH2-, or the like; Y1, Y2, Y3 and Y4 stand for -CH-, -CF-, -N-, or the like; Z stands for lower alkyl, an aliphatic heterocyclic group, or the like; Ar is a mono- or bi-cyclic aliphatic heterocycle or an aromatic heterocycle; and n is an integer of 1 to 8]. The compounds act as antagonist against melanin-concentrating hormone receptor and are useful as drugs for central diseases, circulatory diseases, or metabolic diseases.
